You are here

Our science / Clinical Trials / Find a Trial / NCT00618007

Effect of PF-00734200 in Subjects With Type 2 Diabetes

Back to Search Print Save as PDF Bookmark Trial

NCT00618007

Last updated on March 15, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, 35205 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Type 2 Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Men or women between 18-80 years of age with poorly controlled Type 2 diabetes

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Type 1 or secondary forms of diabetes Currently using insulin

NCT00618007
Pfizer
Completed
Effect of PF-00734200 in Subjects With Type 2 Diabetes

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
NCT00527397
All Genders
16+
Years
Multiple Sites
Erectile Dysfunction, Type 2 Diabetes Mellitus
A Multicenter, Double-Blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes
NCT00645268
Males
35+
Years
Multiple Sites
Type 2 Diabetes Mellitus
A Single Dose Study Of PF-05161704 In Healthy Volunteers
NCT01183715
All Genders
18+
Years
New Haven, Connecticut
Type 2 Diabetes Mellitus, NIDDM
Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes
NCT01272804
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now